ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 133 filers reported holding ANAPTYSBIO INC in Q3 2020. The put-call ratio across all filers is 62.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $940,000 | -8.1% | 43,600 | -8.4% | 0.00% | 0.0% |
| Q4 2020 | $1,023,000 | +43.1% | 47,586 | -1.9% | 0.00% | 0.0% |
| Q3 2020 | $715,000 | -32.3% | 48,486 | +2.5% | 0.00% | 0.0% |
| Q2 2020 | $1,056,000 | +36.8% | 47,286 | -13.4% | 0.00% | 0.0% |
| Q1 2020 | $772,000 | -10.0% | 54,626 | +3.5% | 0.00% | 0.0% |
| Q4 2019 | $858,000 | -47.2% | 52,800 | +13.8% | 0.00% | -50.0% |
| Q3 2019 | $1,624,000 | +15.1% | 46,400 | +85.6% | 0.00% | 0.0% |
| Q2 2019 | $1,411,000 | -22.1% | 25,000 | +0.8% | 0.00% | 0.0% |
| Q1 2019 | $1,812,000 | +12.7% | 24,800 | -1.6% | 0.00% | 0.0% |
| Q4 2018 | $1,608,000 | -19.1% | 25,200 | +26.5% | 0.00% | -33.3% |
| Q3 2018 | $1,987,000 | +33.1% | 19,918 | -5.2% | 0.00% | +50.0% |
| Q2 2018 | $1,493,000 | -40.8% | 21,018 | -13.2% | 0.00% | -50.0% |
| Q1 2018 | $2,520,000 | – | 24,210 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $65,033,000 | 13.01% |
| EcoR1 Capital, LLC | 7,521,024 | $186,070,000 | 5.82% |
| GREAT POINT PARTNERS LLC | 700,000 | $17,318,000 | 4.18% |
| Frazier Life Sciences Management, L.P. | 899,700 | $22,259,000 | 1.90% |
| Boxer Capital, LLC | 1,300,000 | $32,162,000 | 1.65% |
| Logos Global Management LP | 300,000 | $7,422,000 | 0.96% |
| Deep Track Capital, LP | 558,782 | $13,824,000 | 0.89% |
| Palo Alto Investors LP | 431,024 | $10,664,000 | 0.82% |
| TCG Crossover Management, LLC | 58,515 | $1,448,000 | 0.58% |
| Rock Springs Capital Management LP | 563,300 | $13,936,000 | 0.35% |